Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells

BACKGROUND: The mechanisms of endocrine resistance are complex, and deregulation of several oncogenic signalling pathways has been proposed. We aimed to investigate the role of the EGFR and Src-mediated STAT3 signalling pathway in tamoxifen-resistant breast cancer cells. METHODS: The ER-positive lum...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Seo Yun, Lee, Heejin, Kim, Seoree, Hong, Ji Hyung, Chun, Sang Hoon, Lee, Hee Yeon, Kang, Keunsoo, Kim, Ho Shik, Won, Hye Sung, Ko, Yoon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371881/
https://www.ncbi.nlm.nih.gov/pubmed/34407787
http://dx.doi.org/10.1186/s12885-021-08641-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371881/
https://www.ncbi.nlm.nih.gov/pubmed/34407787
http://dx.doi.org/10.1186/s12885-021-08641-7

Ejemplares similares